| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, R&D | See Remarks
1 company
Bergstrom Donald A serves as a President, R&D at RLAY. Across recent SEC filings that breaks down to 0 buys and 62 sells. Those positions are worth an estimated $7.6M at current prices.
Historically, Bergstrom Donald A's trades have earned a strong insider score of 74/100 across 54 rated trades. Over a 12-month horizon, 80.8% of those trades were profitable, with an average 12-month return of +21.6%.
The biggest single holding is RLAY (~$7.6M) as President, R&D. The recent filings there lean toward selling, a net 651,439 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 30, 2023 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 3,451 | $6.03 | $20,809.53 | -1.4% | +59.6% | -5.3% | |
| Sep 27, 2023 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 648 | $8.38 | $5,430.24 | -0.3% | +39.0% | -10.4% | |
| Jul 28, 2023 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 2,683 | $11.80 | $31,659.40 | -1.1% | -48.2% | -26.9% | |
| Jun 27, 2023 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 647 | $12.12 | $7,841.64 | -0.3% | -33.1% | -50.2% | |
| Apr 28, 2023 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 1,383 | $11.16 | $15,434.28 | -0.6% | +2.9% | -44.0% | |
| Mar 27, 2023 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 763 | $15.36 | $11,719.68 | -0.3% | -21.8% | -51.1% | |
| Jan 30, 2023 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 1,429 | $21.56 | $30,809.24 | -0.6% | -45.4% | -54.5% | |
| Dec 27, 2022 | RLAY Relay Therapeutics, Inc. | President, R&D | Sell | 980 | $14.49 | $14,200.20 | -1.1% | +7.4% | -20.9% | |
| Nov 1, 2022 | RLAY Relay Therapeutics, Inc. | President, R&D | Sale+OE | 9,817 | $22.53 | $221,138.18 | -10.2% | -6.7% | -69.6% | |
| Oct 3, 2022 | RLAY Relay Therapeutics, Inc. | President, R&D | Sale+OE | 8,000 | $22.43 | $179,440.00 | -8.3% | -32.6% | -60.8% |